- Home
- OGN
OGN
Organon & Co.
as 05-30-2025 4:00pm EST
| Founded: | 1923 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $18.00 | AVG Volume (30 days): | 7.6M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.88 | EPS Growth: | -29.44 |
| 52 Week Low/High: | $8.01 - $23.10 | Next Earning Date: | 05-01-2025 |
| Revenue: | $6,294,000,000 | Revenue Growth: | -0.83% |
| Revenue Growth (this year): | -1.81% | Revenue Growth (next year): | 1.00% |
Stock Insider Trading Activity of Organon & Co. (OGN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| COX CARRIE SMITH | OGN | Director | May 14 '25 | Buy | $8.07 | 12,469 | $100,591.16 | 12,469 | |
| Weaver Kirke | OGN | Gen. Counsel & Corp. Secy. | May 6 '25 | Buy | $9.21 | 8,045 | $74,054.23 | 52,489 | |
| WALSH MATTHEW M | OGN | Chief Financial Officer | May 5 '25 | Buy | $8.82 | 11,400 | $100,548.00 | 144,484 |
Latest Organon & Co. News
OGN Breaking Stock News: Dive into OGN Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
Argus Research
18 days ago
OGN: Rating decreased to a HOLD
Simply Wall St.
23 days ago
CEO & Director of Organon Picks Up 14% More Stock
Simply Wall St.
24 days ago
Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment
Simply Wall St.
25 days ago
Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon
Argus Research
25 days ago
Daily – Vickers Top Buyers & Sellers for 05/07/2025
Argus Research
25 days ago
OGN: Lowering target price to $10.00
TipRanks
a month ago
Organon price target lowered to $10 from $11 at BofA
Compare OGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OGN Organon & Co. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.